Display options
Cite
Su RJ, Jonas BA, Welborn J, et al. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016;5:6-9doi: 10.1016/j.ehpc.2015.10.001.
Su, R. J., Jonas, B. A., Welborn, J., Gregg, J. P., & Chen, M. (2016). Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Human pathology (New York), 56-9. https://doi.org/10.1016/j.ehpc.2015.10.001
Su, Ruijun Jeanna, et al. "Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia." Human pathology (New York) vol. 5 (2016): 6-9. doi: https://doi.org/10.1016/j.ehpc.2015.10.001
Su RJ, Jonas BA, Welborn J, Gregg JP, Chen M. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016 Sep;5:6-9. doi: 10.1016/j.ehpc.2015.10.001. PMID: 27458550; PMCID: PMC4957580.
Copy Download .nbib Format: NLM
Share it on

Hum Pathol (N Y). 2016 Sep;5:6-9. doi: 10.1016/j.ehpc.2015.10.001.

Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia.

Human pathology (New York)

Ruijun Jeanna Su, Brian A Jonas, Jeanna Welborn, Jeffrey Paul Gregg, Mingyi Chen

Affiliations

  1. Department of Pathology and Laboratory Medicine, University of California at Davis Medical Center, Sacramento, CA 95817.
  2. Division of Hematology and Oncology, University of California at Davis Medical Center, Sacramento, CA 95817.

PMID: 27458550 PMCID: PMC4957580 DOI: 10.1016/j.ehpc.2015.10.001

Abstract

The 2008 World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues introduced a category for myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Many of these patients are responsive to tyrosine kinase inhibitor (TKI) therapy. In this

Keywords: Chronic eosinophilic leukemia; Myeloid proliferative neoplasm with eosinophilia; NOS; Novel ETV6-ACSL6 gene fusion

References

  1. Leukemia. 2006 Jun;20(6):1175-8 - PubMed
  2. Leuk Lymphoma. 1996 Oct;23(3-4):287-95 - PubMed
  3. Blood. 2002 Mar 1;99(5):1776-84 - PubMed
  4. BMC Mol Biol. 2006 Jul 11;7:21 - PubMed
  5. Blood. 2013 Aug 8;122(6):999-1006 - PubMed
  6. Leuk Res. 2012 Aug;36(8):945-61 - PubMed
  7. Cancer Cell. 2002 Nov;2(5):367-76 - PubMed
  8. N Engl J Med. 1991 Apr 18;324(16):1110-8 - PubMed
  9. Semin Hematol. 2013 Oct;50(4):333-47 - PubMed
  10. Blood. 1989 May 1;73(6):1487-97 - PubMed
  11. Genes Chromosomes Cancer. 1999 Nov;26(3):192-202 - PubMed
  12. Biochem J. 1999 Nov 15;344 Pt 1:135-43 - PubMed
  13. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8398-402 - PubMed
  14. Cancer Genet Cytogenet. 2007 Oct 1;178(1):85-8 - PubMed
  15. Cancer. 2014 Mar 15;120(6):799-807 - PubMed

Publication Types

Grant support